rs12144344 — ST6GALNAC3

ST6GALNAC3 — Glycosylation Shapes How Much Vitamin D Your Body Carries

Vitamin D does not travel through the bloodstream on its own. Around 85–90% of circulating vitamin D is bound to a carrier protein called vitamin D-binding protein¹¹ vitamin D-binding protein
VDBP, also known as GC-globulin, is a glycoprotein encoded by the GC gene on chromosome 4. It carries most of the 25(OH)D and 1,25(OH)2D in the blood and determines how long vitamin D stays in circulation. (VDBP). The rs12144344 variant in the ST6GALNAC3 gene represents an emerging link between the biology of protein glycosylation and vitamin D status — a pathway that influences how VDBP is processed and how much of it circulates in your blood.

The Mechanism

ST6GALNAC3 encodes a sialyltransferase²² sialyltransferase
An enzyme that attaches sialic acid residues to the ends of sugar chains on glycoproteins and glycolipids, modifying their structure, stability, and biological activity enzyme that adds sialic acid residues to O-linked glycan chains on glycoproteins. VDBP itself is a glycoprotein: the Gc1 isoforms (the most common forms) carry an O-linked trisaccharide at threonine 418 that includes a terminal sialic acid residue. The terminal sialic acid is added by a sialyltransferase, and ST6GalNAc family enzymes are strong candidates for this modification. Variants in ST6GALNAC3 may alter the enzyme's activity, changing the sialylation state of VDBP. Different sialylation patterns affect VDBP's isoelectric properties, half-life in circulation, and possibly its overall concentration. The rs12144344 variant lies in an intron and most likely influences gene expression or splicing rather than the enzyme's active site directly.

The Evidence

In a genome-wide association study of 1,380 Finnish men³³ genome-wide association study of 1,380 Finnish men
Moy KA et al. Genome-wide association study of circulating vitamin D-binding protein. Am J Clin Nutr, 2014 from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) cohort, rs12144344 was the third strongest genetic signal for circulating VDBP levels. Each copy of the T allele was associated with an increase of approximately 396 nmol/L in serum VDBP (SE = 80.21, P = 5.9 × 10⁻⁷). Across genotype groups, mean VDBP concentrations were 5,408 nmol/L (CC), 5,825 nmol/L (CT), and 6,200 nmol/L (TT) — a roughly 15% step-wise increase per allele. This was the first genome-wide scan for VDBP as a distinct biochemical endpoint and the first study to implicate ST6GALNAC3 in vitamin D biology.

The association was genome-wide suggestive (P < 5 × 10⁻⁶) in the European cohort but was not replicated in an African-ancestry GWAS of VDBP⁴⁴ African-ancestry GWAS of VDBP
Wang et al. 2023 — GWAS of circulating vitamin D outcomes among individuals of African ancestry, n = 9,536. PMC10196601 (β = −0.06, SE = 0.04, P = 0.17), suggesting the effect may be population-specific or that the original signal was driven by European-ancestry linkage disequilibrium. The variant has not been assessed in large vitamin D GWAS as a direct endpoint.

Because this variant affects VDBP concentration (total carrier protein) rather than the vitamin D activation or receptor pathway, it operates differently from the major GC variants (rs7041, rs4588). Higher VDBP means more protein-bound vitamin D in circulation but does not necessarily mean more biologically active (free) vitamin D at the cellular level.

Practical Implications

TT homozygotes in the European cohort had VDBP concentrations approximately 15% above CC homozygotes. Higher VDBP generally means higher total 25(OH)D on standard blood tests, but free (biologically active) vitamin D may not increase proportionally — more carrier protein can sequester more vitamin D without increasing delivery to tissues. This raises the possibility that TT carriers with seemingly adequate total 25(OH)D may have less freely available vitamin D at the cellular level.

The effect size is modest compared to the primary GC variants (rs7041 and rs4588 each account for much larger differences in VDBP), and the lack of replication in non-European populations means this variant should be interpreted cautiously. Where available, testing free 25(OH)D alongside total provides a more complete picture of functional vitamin D status.

Interactions

The primary determinants of serum VDBP and vitamin D transport are rs7041 and rs4588 in the GC gene itself. rs12144344 appears to modulate VDBP levels through a separate glycosylation pathway, making it biologically additive to (rather than redundant with) the GC variants. If an individual carries both higher-VDBP GC alleles and the rs12144344-T allele, the combined effect on total VDBP concentration — and the gap between total and free vitamin D — could be greater than either variant alone. This interaction has not been formally studied.